z-logo
open-access-imgOpen Access
The role of multikinase inhibitors target therapy in radioiodine-resistant differentiated thyroid cancer
Author(s) -
P. O. Rumyantsev
Publication year - 2015
Publication title -
clinical and experimental thyroidology
Language(s) - English
Resource type - Journals
eISSN - 2310-3787
pISSN - 1995-5472
DOI - 10.14341/ket2015225-32
Subject(s) - medicine , lenvatinib , sorafenib , thyroid cancer , oncology , radiation therapy , adverse effect , radioiodine therapy , thyroid , hepatocellular carcinoma

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom